Literature DB >> 16455755

Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells.

Katia Fecchi1, Daniela Volonte, Michael P Hezel, Kevin Schmeck, Ferruccio Galbiati.   

Abstract

Skeletal muscle tissue is one of the main sites where glucose uptake occurs in response to insulin. The glucose transporter type-4 (GLUT4) is primarily responsible for the insulin-stimulated increase in glucose uptake. Upon insulin stimulation, GLUT4 is recruited from intracellular reserves to the plasma membrane. The molecular mechanisms that regulate the translocation of GLUT4 to the sarcolemma remain to be fully identified. Here, we demonstrate that GLUT4 is localized to perinuclear stores that contain flotillin-1, a marker of lipid rafts, in skeletal muscle cells. Stimulation with insulin for 10 min results in the translocation of flotillin-1/GLUT4-containing domains to the plasma membrane in a PI3K- and PKCzeta-dependent manner. We also demonstrate that caveolin-3, a marker of caveolae, is required for the insulin receptor-mediated activation of the PI3K-dependent pathway, which occurs 2 min after insulin stimulation. In fact, we demonstrate that lack of caveolin-3 significantly reduces insulin-stimulated glucose uptake in caveolin-3 null myotubes by inhibiting both PI3K and Akt, as well as the movement of GLUT4 to the plasma membrane. Interestingly, caveolin-3 moves away from the plasma membrane toward the cytoplasm 5 min after insulin stimulation and temporarily interacts with flotillin-1/GLUT4-containing domains before they reach the sarcolemma, with the consequent movement of the insulin receptor from caveolin-3-containing domains to flotillin-1-containing domains. Such translocation temporally matches the insulin-stimulated movement of Cbl and CrkII in flotillin-1/GLUT4-containing domains, as well as the activation of the GDP-GTP exchange factor C3G. Disruption of flotillin-1-based domains prevents the activation of C3G, movement of GLUT4 to the sarcolemma, and glucose uptake in response to insulin. Thus, the activation of the Cbl/C3G/TC10-dependent pathway, which occurs before flotillin-1/GLUT4-containing domains reach the plasma membrane, is flotillin-1 mediated and follows the activation of the PI3K-mediated signaling. Taken together, these results indicate that flotillin-1 and caveolin-3 may regulate muscle energy metabolism through the spatial and temporal segregation of key components of the insulin signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455755      PMCID: PMC4288748          DOI: 10.1096/fj.05-4661fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  78 in total

1.  The dually acylated NH2-terminal domain of gi1alpha is sufficient to target a green fluorescent protein reporter to caveolin-enriched plasma membrane domains. Palmitoylation of caveolin-1 is required for the recognition of dually acylated g-protein alpha subunits in vivo.

Authors:  F Galbiati; D Volonte; D Meani; G Milligan; D M Lublin; M P Lisanti; M Parenti
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

Review 2.  Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane.

Authors:  T Okamoto; A Schlegel; P E Scherer; M P Lisanti
Journal:  J Biol Chem       Date:  1998-03-06       Impact factor: 5.157

3.  Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts.

Authors:  U Salzer; R Prohaska
Journal:  Blood       Date:  2001-02-15       Impact factor: 22.113

4.  Reduction of caveolin and caveolae in oncogenically transformed cells.

Authors:  A J Koleske; D Baltimore; M P Lisanti
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

5.  Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.

Authors:  T Okada; Y Kawano; T Sakakibara; O Hazeki; M Ui
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

6.  Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells.

Authors:  S W Lee; C L Reimer; P Oh; D B Campbell; J E Schnitzer
Journal:  Oncogene       Date:  1998-03       Impact factor: 9.867

7.  Insulin resistance in skeletal muscles of caveolin-3-null mice.

Authors:  Jin Oshikawa; Koji Otsu; Yoshiyuki Toya; Takashi Tsunematsu; Raleigh Hankins; Jun-ichi Kawabe; Susumu Minamisawa; Satoshi Umemura; Yasuko Hagiwara; Yoshihiro Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

Review 8.  The H-2KbtsA58 transgenic mouse: a new tool for the rapid generation of novel cell lines.

Authors:  M Noble; A K Groves; P Ataliotis; Z Ikram; P S Jat
Journal:  Transgenic Res       Date:  1995-07       Impact factor: 2.788

9.  Ultrastructural evidence of differential solubility in Triton X-100 of endothelial vesicles and plasma membrane.

Authors:  N I Moldovan; C Heltianu; N Simionescu; M Simionescu
Journal:  Exp Cell Res       Date:  1995-07       Impact factor: 3.905

10.  Phenotypic behavior of caveolin-3 mutations that cause autosomal dominant limb girdle muscular dystrophy (LGMD-1C). Retention of LGMD-1C caveolin-3 mutants within the golgi complex.

Authors:  F Galbiati; D Volonte; C Minetti; J B Chu; M P Lisanti
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

View more
  46 in total

1.  Intoxication of zebrafish and mammalian cells by cholera toxin depends on the flotillin/reggie proteins but not Derlin-1 or -2.

Authors:  David E Saslowsky; Jin Ah Cho; Himani Chinnapen; Ramiro H Massol; Daniel J-F Chinnapen; Jessica S Wagner; Heidi E De Luca; Wendy Kam; Barry H Paw; Wayne I Lencer
Journal:  J Clin Invest       Date:  2010-12       Impact factor: 14.808

Review 2.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

Review 3.  Changes in the plasma membrane in metabolic disease: impact of the membrane environment on G protein-coupled receptor structure and function.

Authors:  Aditya J Desai; Laurence J Miller
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

Review 4.  Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.

Authors:  Yousuke T Horikawa; Yasuo M Tsutsumi; Hemal H Patel; David M Roth
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 5.  Exacerbation of pathology by oxidative stress in respiratory and locomotor muscles with Duchenne muscular dystrophy.

Authors:  John M Lawler
Journal:  J Physiol       Date:  2011-03-08       Impact factor: 5.182

Review 6.  Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.

Authors:  Latha Ramalingam; Eunjin Oh; Debbie C Thurmond
Journal:  Cell Mol Life Sci       Date:  2012-10-10       Impact factor: 9.261

7.  Cooperative actions of Tbc1d1 and AS160/Tbc1d4 in GLUT4-trafficking activities.

Authors:  Hiroyasu Hatakeyama; Taisuke Morino; Takuya Ishii; Makoto Kanzaki
Journal:  J Biol Chem       Date:  2018-11-27       Impact factor: 5.157

8.  Kinetics of contraction-induced GLUT4 translocation in skeletal muscle fibers from living mice.

Authors:  Hans P M M Lauritzen; Henrik Galbo; Taro Toyoda; Laurie J Goodyear
Journal:  Diabetes       Date:  2010-07-09       Impact factor: 9.461

9.  Peroxisome proliferator-activated receptor-gamma agonist improves skeletal muscle insulin signaling in the pregestational intrauterine growth-restricted rat offspring.

Authors:  Shilpa Oak; Cang Tran; Maria-Olivia Castillo; Shanthie Thamotharan; Manikkavasagar Thamotharan; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-02       Impact factor: 4.310

10.  Caveolin-3 promotes nicotinic acetylcholine receptor clustering and regulates neuromuscular junction activity.

Authors:  Michael Hezel; William C de Groat; Ferruccio Galbiati
Journal:  Mol Biol Cell       Date:  2009-11-25       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.